This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Dec;25(Suppl 3):844-845.

doi: 10.1245/s10434-018-6892-9. Epub 2018 Oct 15.

ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei

Dario Baratti¹

Affiliations

Affiliation

¹ Peritoneal Malignancy Program, Department of Surgery, National Cancer Institute, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. dario.baratti@istitutotumouri.mi.it.

PMID: 30324483
DOI: 10.1245/s10434-018-6892-9

Comment

ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei

Dario Baratti. Ann Surg Oncol. 2018 Dec.

. 2018 Dec;25(Suppl 3):844-845.

doi: 10.1245/s10434-018-6892-9. Epub 2018 Oct 15.

Author

Dario Baratti¹

Affiliation

¹ Peritoneal Malignancy Program, Department of Surgery, National Cancer Institute, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. dario.baratti@istitutotumouri.mi.it.

PMID: 30324483
DOI: 10.1245/s10434-018-6892-9

No abstract available

PubMed Disclaimer

Comment on

Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M. Baratti D, et al. Ann Surg Oncol. 2018 Feb;25(2):404-413. doi: 10.1245/s10434-017-6252-1. Epub 2017 Nov 20. Ann Surg Oncol. 2018. PMID: 29159742 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information